Dissection of the mechanisms of action of evolutionarily conserved apoptotic pathway components

Funded Activity Summary

Animals eliminate unwanted cells through a highly controlled process termed apoptosis. Defects in apoptosis can contribute to cancer or autoimmune disease. Conversely, diseases such as stroke and Alzheimer's disease have been linked to excessive cell death. To develop drugs that promote apoptosis when it fails to occur, or prevent inappropriate cell death, it is necessary to elucidate the molecular mechanisms controlling apoptosis. The first recognised component of the mammalian cell death machinery was Bcl-2; a protein associated with development of cancer. Despite much research since then, the way in which Bcl-2 and related proteins function is still unknown. This project capitalises on previous genetic and biochemical studies in a model genetic organism (the roundworm) to address this important issue. Animal cell death pathway components can be introduced into yeast such that activation of the introduced pathways leads to yeast death and its inhibition promotes yeast survival. We have used this approach to reconstitute the worm cell death pathway and a major mammalian apoptosis pathway in yeast. Yeast strains bearing these reconstituted pathways will be used to test functional equivalence of candidate mammalian proteins and their putative roundworm counterparts. The system will also be exploited to identify and characterise novel proteins that regulate cell death in mammals and worms. Understanding the way in which key molecules regulate apoptosis will assist in the development of diagnostic and therapeutic reagents for many diseases in which cell death regulation is perturbed. This project capitalises on the evolutionary conservation of apoptosis to characterise the mechanisms of action of important mammalian apoptotic regulators and to seek novel mammalian apoptotic pathway components. Proteins identified in this way are likely to be important apoptotic regulators, as our approach ensures that their functions are evolutionarily conserved.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2006

Funding Scheme: NHMRC Project Grants

Funding Amount: $253,500.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cell Development (Incl. Cell Division And Apoptosis)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Autoimmune disease | Bcl-2 | Cancer | Caspase | Degenerative disease | Nematode | Signal transduction | Yeast

Related Links